Rare diseases
Investigational molecules
Locations
331 conditions with trials, the busiest first
872 trials across Europe, recruiting first
A study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
BelgiumStudy of SAT-3247 Compared to Placebo for Patients with Duchenne Muscular Dystrophy Who Can Walk
BelgiumA Study of Cizutamig for Patients with Severe Autoimmune Inflammatory Diseases That Did Not Respond to Previous Treatments
GermanyA study testing tulisokibart for people with rheumatoid arthritis who have not responded well enough to previous treatments
GermanyStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
FranceStudy of BMN 351 given by intravenous infusion to evaluate safety and tolerability in patients with Duchenne Muscular Dystrophy
ItalyStudy of Descartes-08 compared to placebo in adults with generalized myasthenia gravis
ItalyStudy of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels
DenmarkStudy of lutikizumab and ravagalimab in adults with moderate to severe rheumatoid arthritis
CzechiaStudy of intra-articular liraglutide (4P004) for patients with knee synovitis and osteoarthritis
DenmarkStudy on Muscle Growth in Healthy Aging and Sarcopenia Patients Using Testosterone Undecanoate and Placebo
NorwayStudy on How Bimekizumab Affects People with Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
GermanyThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
